Case report
A 64-year-old man was referred with acute tubular necrosis that developed after intravenous antihypertensive treatment. The results of initial haematological investigations (figure) were: haemoglobin concentration 13-7 g/dl, mean corpuscular volume -84 fl, white cell count 10-2 x 109/l1 (10 200/mm3) with a normal differential count. The reticulocyte count was <1 %. His platelet count was 280 x 109/1 (280 000/mm3), prothrombin time 12 s (control 12 s), partial thromboplastin time 40 s, (control 38 s), fibrin degredation products. <10 mg/l. His urine to serum osmolarity ratio was <1-0, and urinary sodium concentration was 40 mmol (mEq)/l. Sediment microscopy showed red and white cells but no casts. Blood and urine cultures were sterile. Renal tomography showed large swollen kidneys.
He required three courses of peritoneal dialysis, each consisting of 40 exchanges, during the oliguric phase of 16 days. During peritoneal dialysis he suddenly had generalised bleeding and blood staining of the dialysate. Repeat investigations showed that his white cell count had fallen to 1-2 x 109/1 (1200/mm3) and the platelets to 12 x 109/1 (12 000/mm3). The haemoglobin was 8-4 g/dl mean corpuscular volume 87 fl, mean corpuscular haemoglobin concentration 32-4 g/dl, and mean corpuscular haemoglobin 28-0 pg. The reticulocyte count was < 1 %. Occasional macrocytes and hypersegmentation of polymorphs were noted on the peripheral blood film. Bone marrow aspirate showed severe megaloblastic change particularly affecting the white cell series. Megakaryocytes were present and the myeloid-erythroid ratio was 11 :1. Folate concentrations measured at the time of the pancytopenia later showed a much diminished serum folate concentration of 0 5 ,tg/l (normal 2-7-20 fg/l) and a normal red cell folate concentration of 224 jug/l (normal 150-1000 jAg/l). His vitamin B1j concentration was 230 ng/l (normal ng/l).
Intravenous folate 10 mg/day was given and his platelet and white cell counts returned to normal levels within four to five days. Associated with this was a mild reticulocyte response of 3 %. He was given a further two-week course of folate 5 mg/day by mouth. He made a satisfactory recovery and when discharged his full blood count and peripheral film were normal and his renal function mildly impaired. His renal function has since improved further and there has been no recurrence of any haematological abnormalities. counts before and after folate treatment in patient who developed acute folate deficiency during peritoneal dialysis.
Comment
Apart from ethanol, which may interfere with the intermediary metabolism of folate, other factors may contribute to the development of acute folate deficiency in severely ill patients.' In normal subjects taking a diet deficient in folate it may be 18 to 20 weeks before megaloblastic changes appear within the bone marrow although serum folate concentrations may become subnormal within two to three weeks. Therefore anorexia probably had only a minor role in our patient. Systemic infection appreciably interferes with jejunal absorption of folate and may also adversely affect folate metabolism.4 Our patient showed no evidence of local or systemic infection at any time. Folate is loosely bound to protein in serum and is thus lost from the body during haemodialysis5'-about 50 ,g in each exchange. Similarly, serum folate is lost during peritoneal dialysis, although how much is lost is uncertain. In the absence of any of the recognised precipitating factors we are tempted to speculate that the recurrent peritoneal dialysis, by rapidly removing folate, played a predominant part in causing our patient's pancytopenia.
The diagnosis depends on being aware of the condition and of the implication of a rapidly developing pancytopenia in a severely ill patient. It is confirmed by examination of a bone marrow aspirate. Because of the delay in recovery of white cell and platelet counts, even after early diagnosis and treatment, we suggest that prophylactic folic acid supplements should be given to patients having repeated peritoneal dialysis. At a minimum white cell and platelet counts should be closely monitored.
